David C. Hohn serves as Executive at CLEVELAND BIOLABS INC, where they oversee executive responsibilities. Since joining the company, David C. Hohn has executed 7 insider transactions totaling $8.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 13, 2014 involved receiving (via award) 22,978 shares valued at $15.6K.
David C. Hohn currently holds 43,049 shares of CLEVELAND BIOLABS INC (CBLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David C. Hohn has been a net buyer of CBLI stock. They have purchased $8.7K and sold $0 worth of shares.
David C. Hohn's most recent insider trade was on Mar 13, 2014, when they sold 22,978 shares at $0.68 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 2, 2012 | CBLI | $1.6K | Purchase | 1,000 | $1.61 | Discretionary |
| Jun 26, 2012 | CBLI | $0 | Award | 5,584 | $N/A | Discretionary |
| Apr 4, 2012 | CBLI | $1.7K | Purchase | 1,000 | $1.71 | Discretionary |
| Jan 4, 2012 | CBLI | $3.0K | Purchase | 1,000 | $2.98 | Discretionary |
| Oct 4, 2011 | CBLI | $2.4K | Purchase | 1,000 | $2.36 | Discretionary |